n order to further promote the rework and production of pharmaceutical industry and marketing of emergent medical supplies, on 2nd April, 2020, Guo Cheng, deputy Director of Consumer Goods Department of Fujian Department of Industry and Information Technology, and his delegation went to investigate the biomedical industry in our district and visited our company for inspection and guidance, accompanied by relevant leaders of Haicang District government.
Li Shicheng, Deputy general manager of administration of our company, and Dr. Song Liuwei were presented. Doctor Song introduced the principle, advantages and market distribution of most of the COVID-19 diagnostic products developed by Xiamen Innodx, as well as related supporting instruments -- automatic Chemiluminescence Immunoassay analyzer. Mr. Li made supplementary reports to the leaders on the development plan of the enterprise in the next 3-5 years.
After listening to the report of Li and Song, director Guo expressed his gratitude to Wantai for taking the lead in responding to the epidemic prevention and control, and was pleased that our products could quickly pass the green channel and get recognition by virious circles. Finally, he hoped that products of Xiamen Innodx could give full play to their advantages and Xiamen Innodx could continue to grow bigger and stronger.
